A granular examination of the US Medical Aesthetics Market segment reveals that the market's structure is highly dependent on procedure type, product category, and end-user setting. By procedure type, the non-surgical segment unequivocally dominates the market, largely driven by the massive consumer appetite for injectables, including neurotoxins (Botox, Dysport, etc.) and dermal fillers...